Abstract: Early protection, early detection, early diagnosis, and early isolation are the key methods to prevent and control an infectious disease like the COVID-19. The detection of SARS-CoV-2 is very important for patient diagnosis. At present, there are two methods to diagnose, nucleic acid test (NAT) and serological test. As a professional enzyme company, Creative Enzymes has the core technology in enzyme modification and expression. During this pandemic, we provide enzyme products for coronavirus nucleic acid detection to help fight against the disease.Summary: The COVID-19 coronavirus disease is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, previously known by the provisional name 2019 novel coronavirus (2019-nCoV), is a positive-sense singlestranded RNA virus). The World Health Organization (WHO) officially announced the COVID-19 outbreak to be a pandemic on March 11, 2020.References: https://www.creative-enzymes.com/pdf/com/Enzymes-for-Coronavirus-Nucleic-Acid-Test.pdf
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Wat is de impact van bewegen op de werkvloer bij verschillende beroepen?
Jhon van Heel
SARS-CoV-2 Introduction_Creative Biolabs
Complement Therapeutics_Creative Biolabs
CAR Design & Construction Service_Creative Biolabs
CARDIAC AMYLOIDOSIS IN SINUS RYTHM : WHY AND HOW TO ANTICOAGULATE ? CASE REPORT AND LITERATURE REVIEW